# Multicenter, Open-Label, Randomised, Haloperidol-controlled Study to Evaluate Seroquel as Mono-Therapy in the Treatment of Agitated Symptoms in the Patients With Acute Episode of Schizophrenia

> **NCT00631722** · NA · COMPLETED · sponsor: **Peking University** · enrollment: 80 (actual)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** Quatiapine Fumarate
- **DRUG:** Haloperidol

## Key facts

- **NCT ID:** NCT00631722
- **Lead sponsor:** Peking University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-05
- **Primary completion:** 2008-01
- **Final completion:** 2008-05
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2012-08-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00631722

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00631722, "Multicenter, Open-Label, Randomised, Haloperidol-controlled Study to Evaluate Seroquel as Mono-Therapy in the Treatment of Agitated Symptoms in the Patients With Acute Episode of Schizophrenia". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT00631722. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*